Category: ENTIS News

Colleagues from CRAT (Centre de Référence sur les Agents Tératogènes, the French Teratology Information Service), in collaboration with Radboud University (the Netherlands), the University of Oslo (Norway), and the IMAGe Center (Quebec, Canada), have conducted a systematic review to describe the mean number of medications used per pregnancy and the prevalence of medication use in Europe and North America. The […]

» Read more

Congratulations to the winners of the best oral abstract presentations (two awards; Nusret Uysal from Terafar, Izmir TIS, and Sharon Daniel from Ben-Gurion University of the Negev) and best poster award (Gro Cecilie Havnen and Anne Katrine Eek from the Norwegian RELIS network).

» Read more

This collaborative study used data from 13 ENTIS centres in eleven countries (Germany, Israel, France, Japan, the United Kingdom, Italy, Australia, Spain, Belgium, the Netherlands and Switzerland), investigated the reproductive safety of direct oral anticoagulants after maternal exposure in early pregnancy. More information is available here. Photo by Roger Brown available via Pexels.com

» Read more

The ENTIS board and all the delegates from ENTIS extend their sincere thanks to the ENTIS 2026 Organising Committee from TIS Lareb for delivering such an excellent and well-organised conference in Leiden (Netherlands). The meeting provided a valuable opportunity to connect with colleagues from across Europe and beyond, share experiences, and learn from leading experts on medicines use during pregnancy […]

» Read more

The 2026 annual ENTIS conference has begun. This year the meeting is being held in Leiden, NL. The ENTIS board express their warm thanks to Miranda van Tuyl and all her colleagues from Lareb TIS who have organised the meeting venue and developed an engaging scientific programme. More details about the conference are available on the website.

» Read more

A collaboration of researchers and clinical experts, led by the REALIFE Research Group at the Research Unit Woman and Child, Department of Development and Regeneration, KU Leuven in Belgium, have published a review and set of clinical guidelines about GLP-1 and GIP medication use in pregnancy and breastfeeding. A link to the Pubmed index here, and the article shared by […]

» Read more

Researchers affiliated with the Swiss Teratology Information Service (Lausanne, Switzerland) have published a study examining the prevalence and patterns of use for IBD medications in the national MAMA cohort (health insurance claims data). More information is available here. Photo by MART PRODUCTION on PEXELS.

» Read more

ENTIS member Laure Sillis will defend her PhD thesis “Real-World Data to Evaluate Medication Safety in Pregnancy” on Thursday, June 4th 2026 at 17:00 (CET) in Leuven, Belgium. The defence will also be accessible via livestream. The thesis explores how different real-world data sources – from self-reported pregnancy registry data to large-scale administrative healthcare databases – can be used to […]

» Read more